Answers are grounded in this paper and cite their sources.
Supplementary Figure S11: ICI-resistant BCCs harbor higher levels of TME2-like CAFs and myeloid cells.
No takes yet. Share an insight, caveat, or question.
Pich-Bavastro et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: